Karnataka urges Centre to extend price-control measures to cardiac and kidney medicines
GS2Polity · Governance · IR· Health policy & public health· Mains·
Pharmaceutical regulation and public health policy: a GS2 case study on balancing affordability and manufacturing sustainability.
Why in news
The Karnataka government urged the Centre to extend price-control measures to cardiac and kidney medicines following the NPPA's decision to cap trade margins on non-scheduled anti-cancer drugs.
Background
The National Pharmaceutical Pricing Authority (NPPA) approved trade margins on non-scheduled anti-cancer medicines at 30% of the Maximum Retail Price (MRP). Karnataka identified pricing concerns for 253 specific medicines in the cardiac and kidney categories.
Facts for Prelims
- FactTrade margins for non-scheduled anti-cancer medicines were approved at 30% of MRP.
- FactKarnataka identified 253 medicines requiring price-control measures.
Prelims practice question
Which body is responsible for approving trade margins on non-scheduled anti-cancer medicines in India?
- (a)National Pharmaceutical Pricing Authority
- (b)Drug Controller General of India
- (c)Food Safety and Standards Authority of India
- (d)Central Drugs Standard Control Organisation
Show answer
Answer: (a) National Pharmaceutical Pricing Authority — The note mentions the National Pharmaceutical Pricing Authority (NPPA) approved trade margins on non-scheduled anti-cancer medicines.
For Mains
Q. Discuss the challenges in balancing pharmaceutical affordability with the sustainability of the domestic drug manufacturing industry in India.
Dimensions to cover in your answer
- Market distortion: Impact of price caps on R&D investment and manufacturing viability for non-scheduled drugs
- Regulatory friction: Coordination between State health priorities and Centralized NPPA pricing frameworks
- Access vs. Innovation: Trade-offs between ensuring affordable cardiac/kidney care and incentivizing private sector production
Keywords: Affordability · Price Control · Pharmaceutical Regulation · Public Health Policy · Market Distortion
More Social Justice notes
- Centre proposes 30% trade-margin cap on cancer drugs to save ₹2,500 crore annually · 12 October 2026
- Justice Nagarathna notes 55% of juvenile cases pending across 18 States and 2 UTs · 12 October 2026
- Karnataka High Court strikes down law increasing SC and ST reservation percentages · 12 October 2026
- Keralam provides work to 9.32 lakh families under Viksit Bharat Rozgar Act · 12 October 2026
- CoverSure CEO warns policyholders to check OPD limits for mental illness coverage · 12 October 2026
- CM C. Joseph Vijay expands VPT to offer no-fare bus travel for women · 11 October 2026
Something wrong, or something missing?
Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.
This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.